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Background: Immune system dysfunction may be associated with eating disorders, and 
associations could have implications for detection, risk assessment, and treatment of both 
autoimmune diseases and eating disorders. However, questions regarding the nature of the 
relationship between these two disease entities remain. We evaluated the strength of 
associations for the bidirectional relationships between eating disorders and autoimmune 
diseases. Methods: In this nationwide population-based cohort study, Swedish registers were 
linked to establish a cohort of more than 2.5 million individuals born in Sweden between 
January 1, 1979 and December 31, 2005 and followed-up until December 2013. Cox 
proportional hazard regression models were used to investigate: 1) subsequent risk of eating 
disorders in individuals with autoimmune diseases; and 2) subsequent risk of autoimmune 
diseases in individuals with eating disorders. Results: We observed a strong, bidirectional 
relationship between the two classes of illness indicating that diagnosis in one illness class 
increased the risk of the other. In women, autoimmune disease diagnoses increased 
subsequent hazard of anorexia nervosa, bulimia nervosa, and other eating disorders. 
Similarly, anorexia nervosa, bulimia nervosa, and other eating disorders increased subsequent 
hazard of autoimmune diseases. The gastrointestinal-related autoimmune diseases celiac 
disease and Crohn's disease showed a bidirectional relationship with anorexia nervosa and 
other eating disorders. Psoriasis showed a bidirectional relationship with other eating 
disorders. Prior type 1 diabetes increased risk for anorexia nervosa, bulimia nervosa, and 
other eating disorders. In men, we did not observe a bidirectional pattern, but prior 
autoimmune arthritis increased risk for other eating disorders. Conclusions: The associations 
between eating disorders and autoimmune diseases provide additional support for previously 
reported associations. The bidirectional risk pattern observed in women suggests either a 












Autoimmunity has been implicated in several psychiatric disorders (Eaton et al., 
2006; Frick & Pittenger, 2016), including eating disorders (for a summary of studies see 
Table S1). Moreover, the first genome-wide significant association in anorexia nervosa (AN) 
was identified (Duncan et al., 2017) in a region previously implicated in autoimmune 
diseases, including type 1 diabetes (Barrett et al., 2009) and arthritis (Okada et al., 2014).  
 Eating disorders and autoimmunity are complex traits influenced by numerous 
genetic variants acting additively in combination with environmental factors to influence 
phenotypic expression (Yilmaz, Hardaway, & Bulik, 2015). Autoimmunity varies on a 
continuum, ranging from no clinical consequences to pathogenic autoimmunity causing 
inflammatory organ infiltration, tissue damage, and overt disease-specific symptomatology. 
Autoimmune diseases occur in ~7-9% of the population and increase with age 
(Theofilopoulos, Kono, & Baccala, 2017). 
Prior epidemiological and molecular genetic evidence of associations between 
autoimmune diseases and eating disorders coupled with the extensive Swedish health 
registers afforded an exploration of bidirectional associations between eating disorders and 
autoimmune diseases (Table S2). We replicated previous findings in an independent sample 
and extended prior studies (Raevuori et al., 2014; Wotton, James, & Goldacre, 2016; Zerwas 
et al., 2017) by examining a cohort of more than 2.5 million individuals. The cohort 
comprises the largest number of female (n = 26,454) and male eating disorder cases (n = 
1,711) providing sufficient statistical power, especially in women, to detect epidemiological 







Study Population and Data Sources  
We studied individuals aged 0-35 years born in Sweden between January 1, 1979 and 
December 31, 2005, excluding those who emigrated or died before age 8, or were from 
multiparous births, to reduce nesting. Individuals were followed until eating disorder onset, 
autoimmune disease onset, death, emigration from Sweden, or the end of the follow-up 
period (December 31, 2013), whichever came first. We linked registers using the national 
personal identification number (Ludvigsson, Otterblad-Olausson, Pettersson, & Ekbom, 
2009). Consistent with prior research (Yao et al., 2016), birth year and sex were from the 
Total Population Register; migration data were from the Migration Register (Statistics 
Sweden); causes of death were from the Cause of Death Register (Statistics Sweden); and 
socioeconomic status (SES) was estimated using highest parental education (i.e., completed 
year 9 or below; completed year 12; >2 years tertiary) from the Longitudinal Integration 
Database for Health Insurance and Labour Market Studies (Ludvigsson et al., 2016) when the 
child was 8 years old. The study was approved by the Regional Ethical Review Board in 
Stockholm, Sweden. 
Eating Disorder Outcomes 
Eating disorder diagnoses were from the National Patient Register (NPR), which 
tracks all inpatient care since 1987 and outpatient care since 2001 (Ludvigsson et al., 2011); 
Riksät-National Quality Register for Treatment for Eating Disorders (since 1999; Emilsson, 
Lindahl, Köster, Lambe, & Ludvigsson, 2015); the regional quality assurance system for 
eating disorders, Stepwise (since 2005; Birgegård, Björck, & Clinton, 2010); and the clinical 
database for child and adolescent psychiatry in Stockholm, Pastill (since 2001; Lindevall, 
2009). NPR discharge diagnoses were from Swedish ICD-9 and from ICD-10 (Smedby, 
2006). In Riksät and Stepwise, eating disorder diagnoses were based on DSM-IV-TR 
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(American Psychiatric Association, 2005). Coverage in Riksät and Stepwise has increased 
over time (Javaras et al., 2015). Pastill eating disorder diagnoses were based on ICD-10 or 
DSM-IV from Child and Adolescent Mental Health Services in Stockholm County 
(Lindevall, 2009). 
 Four eating disorder outcomes were evaluated: 1) AN: 307B (Swedish ICD-9); F50.0 
or F50.1 (ICD-10); or DSM-IV AN or atypical AN; 2) Other eating disorders: 307F (Swedish 
ICD-9); F50.2, F50.3, or F50.9 (ICD-10); or DSM-IV bulimia nervosa (BN), atypical BN, 
binge-eating disorder (BED), or eating disorder not otherwise specified (EDNOS); 3) Any 
eating disorder: included all individuals with an AN, BN, and/or other eating disorder 
diagnosis. Consistent with previous reports (Stice, Marti, & Rohde, 2013), many individuals 
had both AN and other eating disorders (at different times) and are included as incident cases 
for both the AN and other eating disorder outcomes. Thus, the number of incident cases of 
AN and/or other eating disorders is greater than the number of incident cases of any eating 
disorder, where each individual can be an incident case only once. Analysis of any eating 
disorder provides information on the overall incidence of eating disorders without inflation 
due to diagnostic crossover. 4) BN: included all individuals who received a BN diagnosis in 
the NPR (ICD-10: F50.2, F50.3) since 1997 or in Riksät, Stepwise, or Pastill. Analyses of BN 
are considered secondary because the years of observation are fewer than for the other 
diagnostic groups. BED and EDNOS could not be separated because Swedish ICD-9 only 
included a heterogeneous category (eating disorders other than AN) and F50.8, from ICD-10, 
was not consistently used to code BED in DSM-IV.  
Age of onset reflects first contact with the respective diagnosis in the NPR, Riksät, 
Stepwise, or Pastill after the 8th birthday. The minimum age of onset for eating disorders was 




Autoimmune Disease Outcome  
Autoimmune disease diagnoses were obtained from the NPR using Swedish ICD 
revisions 8-9 and ICD-10 diagnoses based on year of diagnosis. We evaluated any 
autoimmune disease as a group, and by specific categories: celiac disease, Crohn's disease, 
ulcerative colitis, psoriasis, arthritis, lupus, and type 1 diabetes (Table S2). Age of onset was 
age at first contact with the respective diagnosis in the NPR with no minimum age of onset.  
Statistical Analyses 
Data management was conducted with SAS version 9.4 analyses were conducted with 
STATA version 14. False discovery rate (FDR) corrections were made for each predefined 
set of hypothesis tests (n=128; Benjamini & Hochberg, 2000). 
To optimize our longitudinal data, we performed two sets of Cox proportional hazard 
regression models estimating the relative hazards of eating disorders following autoimmune 
disease diagnosis and autoimmune disease risk following eating disorder diagnosis. In the 
first set, autoimmune disease status (presence/absence) was treated as time-dependent 
diagnosis and calendar year (1987-1996, 1997-2006, 2007-2013) was adjusted for as a time 
varying variable; all other variables were considered time-independent. For each analysis, we 
estimated hazard ratios (HR) for eating disorders in individuals exposed to an autoimmune 
disease compared to those not exposed. In the second set of analyses, we estimated HRs for 
autoimmune diseases, comparing individuals exposed to an eating disorder to those not 
exposed, with eating disorder diagnosis as a time-varying diagnosis variable (i.e., event 
occurring prior to an outcome). All estimates were adjusted for calendar-time in the 
parametric part of the Cox model, and for age in the nonparametric part. SES was entered as 
a covariate into all models. In Cox models, HRs greater than 1 indicate a higher risk of 
illness, whereas HRs less than 1 indicate a lower risk of illness compared with unaffected 
individuals. Analyses were applied to males and females separately.  
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Significantly increased HRs, after FDR correction, for an autoimmune disease after 
eating disorder diagnosis were investigated for effects of temporal proximity by calculating 
HR for ≤1 year, >1 year to ≤4 years, and >4 years between first and second diagnosis. Due to 
possible misdiagnosis of eating disorders before age 8, we did not explore temporal proximity 
between a prior diagnosis of an autoimmune disease and eating disorder onset. Furthermore, 
we did not investigate different ages of eating disorder onset as age of onset distributions 
revealed no evidence of bi- or multimodal patterns justifying such an approach, rendering any 
age at onset cut-off arbitrary (Figures 1a and 1b). 
 
Results  
Our cohort comprised 2,545,611 individuals (51.4% males, 48.6% females) followed 
over 33,640,644 person-years (range: 1 month to 22 years).  
Sample characteristics 
Table 1 presents prevalence and age at first diagnosis. Eating disorders occurred more 
commonly in females (2.0%) than in males (0.1%): 94% of eating disorder cases were 
female. 
 The most common autoimmune diseases were celiac disease, type 1 diabetes, and 
psoriasis. A higher percentage of females than males were diagnosed with an autoimmune 
disease.   
 
Risk of Eating Disorders Following Autoimmune Disease Diagnosis 
Tables S3a and S3b provide the results from the Cox regression models estimating 
HRs of eating disorders after an autoimmune disease diagnosis in males and females, 
respectively. We discuss only significant results. 
In males, any preceding autoimmune disease was associated with an 82% increased 
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hazard in other eating disorders, a 78% increased hazard in any eating disorder, and a 56% 
increased hazard for BN. In females, any preceding autoimmune disease increased the hazard 
for AN by 59%, for other eating disorders by 71%, for any eating disorder by 62%, and for 
BN by 57%. 
We also evaluated the risk for subsequent eating disorders following diagnosis of 
celiac disease, Crohn's disease, ulcerative colitis, psoriasis, arthritis, lupus, and type 1 
diabetes. In males, diagnosis of arthritis increased the risk for other eating disorders by 357% 
and any eating disorder by 267%, however, the assumption of proportional hazards was 
violated (Figure 2a). In females, the risk for subsequent AN was increased after celiac disease 
(50%), Crohn’s disease (89%), and type 1 diabetes (71%). Moreover, celiac disease (47%), 
Crohn’s disease (63%), ulcerative colitis (52%), psoriasis (33%), and type 1 diabetes (153%) 
increased risk for subsequent other eating disorders. Risk for any eating disorder was 
increased after diagnosis of celiac disease (45%), Crohn’s disease (61%), ulcerative colitis 
(49%), psoriasis (27%), and type 1 diabetes (119%). Risk for subsequent BN was increased 
by 222% by an earlier diagnosis of type 1 diabetes (Figure 2c).  
Risk of Autoimmune Disease Following an Eating Disorder Diagnosis 
Tables S4a and S4b provide the results from the Cox regression models estimating 
risk for subsequent autoimmune disease following an eating disorder diagnosis in males and 
females. After correcting for multiple testing, we did not observe an increased risk for 
autoimmune diseases after eating disorder diagnosis in men. However, females with AN 
(42%), other eating disorders (58%), any eating disorder (53%), or BN (48%) were at 
increased risk for later any autoimmune disease. 
We evaluated the risk for celiac disease, Crohn's disease, ulcerative colitis, psoriasis, 
arthritis, lupus, and type 1 diabetes following a diagnosis of each of the eating disorder 
groups in males and females. Males diagnosed with eating disorders did not show an 
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increased risk for subsequent autoimmune diseases after correcting for multiple testing 
(Figure 2b). In females, prior diagnosis of AN (83%), other eating disorders (69%), and any 
eating disorder (72%) increased risk for celiac disease. Other eating disorders (72%) and any 
eating disorder diagnosis (63%) showed increased risk for Crohn's disease. A diagnosis of 
other eating disorders increased the risk for subsequent psoriasis by 38% (Figure 2d). 
Temporal Proximity of Risk of Autoimmune Disease Following an Eating Disorder Diagnosis 
We explored effects of temporal proximity between eating disorder diagnosis and risk 
for autoimmune disease in females (Table S5) as only females had significant findings. A 
prior diagnoses of AN was associated with an increased risk (105%) of being diagnosed with 
any autoimmune disease within the first year after AN diagnosis and with a 49% increased 
risk between years 1 and 4. Similarly, risk for celiac disease was increased 217% within the 
first year and 84% in years 1 to 4 after AN diagnosis. A prior diagnoses of other eating 
disorders increased the risk of being diagnosed with any autoimmune disease for all three 
time periods: 216% for 1 year after diagnosis; 47% for 1 to 4 years between diagnoses; and 
45% for >4 years. Other eating disorders increased the risk of being diagnosed with celiac 
disease (165%) and Crohn’s disease (188%) within the first year. The increased risk for 
celiac disease persisted between 1 year and 4 years at 55%. Within the first year, females 
with any eating disorder were at 114% increased risk of developing any autoimmune disease; 
48% increased risk between years 1 and 4; and 32% increased risk >4 years. Any eating 
disorder increased the risk for celiac disease and Crohn's disease within the first year after 
diagnoses by 189% and 202%, respectively. The risk of being diagnosed with celiac disease 
persisted between years 1 and 4 at 58%. BN was associated with a 79% increased risk for any 






With 2.5 million participants and over 26,000 individuals diagnosed with an eating 
disorder, to our knowledge, this is the largest prospective register-based study examining the 
bidirectional associations between autoimmune diseases and eating disorders. We observed 
positive and strong associations between eating disorders and autoimmune diseases that are 
on par with reported associations in epidemiological investigations between autoimmune 
diseases and other psychiatric disorders (Benros et al., 2014; Euesden, Danese, Lewis, & 
Maughan, 2017). We extended previous observations by investigating a variety of 
autoimmune diseases previously associated with eating disorders in case reports, clinical 
samples, and smaller cohort studies (Wotton et al., 2016). Our results replicate bidirectional 
risk patterns of eating disorders and autoimmune diseases explored in two clinical cohort 
studies (Raevuori et al., 2014; Wotton et al., 2016) and a Danish national study (Zerwas et al., 
2017).  
In men, we did not observe any bidirectional patterns. Preceding autoimmune arthritis 
and type 1 diabetes increased the risk for other eating disorders and preceding autoimmune 
arthritis increased the risk for any eating disorder. The UK study also observed a significantly 
increased risk for BN in males with type 1 diabetes based on reports from five cases (Wotton 
et al., 2016).  
In women, AN showed a bidirectional relationship with celiac disease, replicating 
reported results (Mårild et al., 2017; Wotton et al., 2016). Crohn’s disease increased risk for 
AN (Raevuori et al., 2014; Wotton et al., 2016), but was not bidirectionally associated 
(Wotton et al., 2016). The gastrointestinal-related autoimmune diseases celiac disease and 
Crohn's disease showed bidirectional relationships with other eating disorders. The Finnish 
study (Raevuori et al., 2014) showed increased odds for Crohn’s disease and BN, whereas the 
UK study (Wotton et al., 2016) found an increased risk for celiac disease after BN. Ulcerative 
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colitis increased risk for other eating disorders. Additionally, psoriasis showed a bidirectional 
relationship with other eating disorders, replicating findings from the UK study (Wotton et 
al., 2016) and clinical case reports (Crosta et al., 2014; Ferreira, Abreu, Reis, & Figueiredo, 
2016). Type 1 diabetes increased risk for AN, other eating disorders, and BN as previously 
reported (Raevuori et al., 2014; Wotton et al., 2016); however, Wotton et al. (2016) reported 
an increased risk for type 1 diabetes after AN and BN which we did not replicate.  
The bidirectional nature of some associations suggests either a shared underlying 
mechanism or a third mediating variable that influences risk for both disease groups. Such 
shared risk-elevating factors could be genetic, environmental, or a combination of both. 
Current evidence suggests that dysregulated immune function may be one shared underlying 
mechanism. Several biological factors influencing immune function are described to be 
predominant or altered in eating disorders: a female preponderance (Chiaroni-Clarke, Munro, 
& Ellis, 2016; Klein & Flanagan, 2016; McCarthy, Nugent, & Lenz, 2017), metabolic 
changes mediated by adipokines such as leptin and adiponectin (Abella et al., 2017), elevated 
cytokines (M. Solmi et al., 2015), abnormal levels of estrogen (Khan & Ansar Ahmed, 2015; 
Klump, Culbert, & Sisk, 2017), and lower abundance or diversity of intestinal microbiota 
(Carr, Kleiman, Bulik, Bulik-Sullivan, & Carroll, 2016; Rooks & Garrett, 2016). These 
factors potentially influence the relationship between eating disorders and autoimmunity. For 
example, cortisol levels are dysregulated in eating disorders (Monteleone et al., 1999) 
possibly due to an altered stress response. Cortisol is often included in the therapeutic 
regimen for autoimmune diseases (Ilzarbe et al., 2017; Straub & Cutolo, 2016). 
Furthermore, Fetissov et al. detected autoantibodies against appetite-regulating 
peptides, including α-Melanocyte-stimulating hormone and adrenocorticotropic hormone in 
AN and BN (Fetissov et al., 2002, 2005, 2008). However, the role of autoantibodies in 
autoimmune diseases is not fully understood. Antibodies may be an epiphenomenon or have a 
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causal effect facilitating aberrant immune cell function leading to cytotoxicity.  
Recent research suggests a genetic overlap between several autoimmune diseases and 
psychiatric disorders; however, the only study that has included eating disorders revealed no 
significant genetic associations between AN and autoimmune diseases or traits (Tylee et al., 
2017). The increased risk for eating disorders after type 1 diabetes could be metabolically 
mediated through a dysregulation of insulin homeostasis, administration of mandatory 
external insulin, and insulin misuse (Bryden et al., 1999; Colton et al., 2015).  
Elevated body dissatisfaction has been reported in adolescent females with type 1 
diabetes (Araia et al., 2017). Moreover, behaviors necessary for diabetes care such as 
carbohydrate monitoring, restriction and portion control, blood sugar control, and regular 
exercise have the potential to transition from healthful to pathological thereby increasing risk 
for eating disorders (Young-Hyman & Davis, 2010). Yet, considerably more research is 
necessary in this area as a second study reported reduced dieting, fasting, and caloric 
restriction in adolescents with type 1 diabetes (Ackard et al., 2008). 
Similarly, increased risk of any eating disorder after ulcerative colitis could be due to 
symptom- and therapy-related behavioral changes as treatment often includes dietary changes 
and a colectomy with pouches or stoma (Ungaro, Mehandru, Allen, Peyrin-Biroulet, & 
Colombel, 2017). Patients suffering from inflammatory bowel disease often report eating 
behavior changes related to their disease, and many perceive food as a risk factor for relapse 
decreasing their pleasure in eating (Zallot et al., 2013). Similarly, the primary treatment 
component for celiac disease is a gluten-free diet that could significantly influence patients’ 
health-related quality of life (Almagro, Almagro, Ruiz, González, & Martínez, 2018; 
McAllister, Williams, & Clarke, 2018). Moreover, the increased risk of being diagnosed with 
a gastrointestinal-related autoimmune disease within the first year of having been diagnosed 
with an eating disorder may suggest diagnostic uncertainty due to the overlap in their clinical 
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presentation complicating the differential diagnosis (Golden & Park, 2017; Tokatly Latzer et 
al., 2018). 
Environmental factors (e.g., diet, dietary behavior, and smoking) also influence the 
human immune system. Starvation and food restriction (as seen in AN) could reduce 
inflammation and attenuate symptoms in autoimmune illnesses (Hafström, Ringertz, 
Gyllenhammar, Palmblad, & Harms-Ringdahl, 1988). For gastrointestinal-associated immune 
diseases, dietary changes are often prescribed to control pain, diarrhea, and bleeding (Lane, 
Zisman, & Suskind, 2017). All of these processes may be active, and the inclusion of genetic, 
biological, and environmental confounders, and a developmental perspective in prospective 
studies are needed to further clarify the relationships between eating disorders and 
autoimmune diseases. 
 
Strengths and Limitations 
Study strengths include the total-population design and substantially more eating 
disorder cases than in previous studies (Mårild et al., 2017; Raevuori et al., 2014; Wotton et 
al., 2016; Zerwas et al., 2017). Prospectively collected data allowed us to explore 
bidirectional risk and minimized the risk of recall bias since data were routinely collected 
blind to the hypothesis of this study. The positive predictive value between diagnoses for 
most chronic diseases in the NPR and medical records is generally 85-95% (Ludvigsson et 
al., 2011). Additionally, we investigated specific autoimmune diseases, which can inform 
disease detection, treatment, and management. Our statistical models were corrected for 
multiple statistical tests unlike previous studies (Raevuori et al., 2014; Wotton et al., 2016) 
and adjusted for socioeconomic status in line with the British sample (Wotton et al., 2016). In 
addition, the British cohort (Wotton et al. 2016) and our cohort share common ancestry which 
renders our findings comparable. 
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The observed bidirectional relationships in females suggest a potential involvement of 
the immune system in some eating disorders. However, we cannot rule out misdiagnosis or 
surveillance bias given symptom overlap of eating disorders, especially with gastrointestinal 
autoimmune diseases, such as Crohn’s diseases, ulcerative colitis, or celiac disease. 
Furthermore, the associations could be a mediated by behaviors, such as eating behavior or 
dietary restrictions. 
Despite the large sample size and follow-up period, some autoimmune disease risk 
periods remain outside study timeline (e.g., rheumatoid arthritis age of onset is typically after 
age 44; Symmons, 2002) and exact ages of disease onset cannot be traced in register data. 
This may also limit the precision of the observed chronological order of eating disorders and 
autoimmune diseases. Both illnesses could develop at the same time, but one may be 
diagnosed with a delay, or, they could be diagnosed in opposite order of their onset. 
Moreover, although the study covers the peak age of onset for eating disorders (Javaras et al., 
2015), individuals remain at risk across the lifespan. A longer follow-up period could alter 
some of the bidirectional relationships. Additionally, we were unable to evaluate BED 
because it could not be distinguished from other eating disorders in the NPR.  
The relatively small number of male eating disorder cases limited our investigation of 
sex differences. However, compared with previous studies, the investigation represents the 
largest number of male eating disorder cases in a population sample. Nevertheless, if male 
eating disorder patients were less likely to seek professional help, this would lead to 
undersampling and could affect our observed sex ratio (Solmi, Hotopf, Hatch, Treasure, & 
Micali, 2016). Given the large overall sample size, small differences in prevalence between 
the sexes would be statistically significant, but their clinical significance questionable. 
Furthermore, the assumptions of proportional hazards were violated in some of the 
associations (Tables S3-S4). Lastly, the Swedish versions of ICD-8 and ICD-9 could not 
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distinguish between type 1 diabetes and type 2 diabetes; however, as our cohort is young 
(≤34 years), most individuals with ICD-8 or ICD-9 diabetes are assumed to have type 1 
diabetes. Diabetes diagnoses according to ICD-10, the largest proportion in our cohort, are 
classified into type 1 or type 2. 
 
Conclusions 
Results support a bidirectional relationship between eating disorders and autoimmune 
processes in females. However, this phenomenon was not observed in males in our sample. 
The findings suggest either a shared mechanism contributing to the associations of eating 
disorders and autoimmune diseases, such as a dysregulation of the immune system or a 
shared genetic vulnerability, or a third mediating variable may be operative, for instance, 
autoimmune disease-related changes of eating behavior, medication effects, or insulin 
dysregulation leading to disturbances of appetite regulation. Clinically, our results encourage 
vigilance for the emergence of autoimmune diseases in patients with disordered eating 
behavior because autoimmune diseases and eating disorders show substantial symptom 
overlap. As the size of genomic investigations of both eating disorders and autoimmune 
diseases increases, we will be well positioned to further explore the extent to which shared 
genetic factors may influence risk for both classes of illness. However, first evidence does not 
support a genetic overlap between autoimmune traits and anorexia nervosa estimated by 
genetic correlations derived from molecular genetic methods (Tylee et al., 2017). The 
finding, however, requires replication and extension to other eating disorder types. 
Identifying common environmental risk factors or mediating metabolic factors, may facilitate 








●   In the largest prospective register-based study to date on eating disorders and 
autoimmune diseases, we replicated strong bidirectional relationships between 
eating disorders and various autoimmune diseases. 
●   The observed positive and strong associations between eating disorders and 
autoimmune diseases are on par with reported associations in epidemiological 
investigations between autoimmune diseases and other psychiatric disorders. 
●   Bidirectional, disorder specific patterns were observed in women, but not in 
men. 
●  The bidirectional risk pattern observed in females suggests either a shared 
underlying mechanism or a third mediating variable contributing to the 
association of these illnesses. 
●  Our results encourage vigilance for the emergence of autoimmune diseases in 
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Table 1. Number (%) of individuals with each eating disorder and autoimmune disease for the total 
sample and by sex. Mean (SD) age at first diagnosis for each illness by sex. 



















Anorexia nervosa  12,227 (0.5) 706 (<0.1) 11,521 (0.9) 16.57 (4.2) 17.91 (4.0) 
Other eating disorder  20,906 (0.8) 1,340 (0.1) 19,566 (1.6) 17.35 (5.0) 19.50 (4.4) 
Any eating disorder  26,454 (1.0) 1,711 (0.1) 24,743 (2.0) 17.03 (4.9) 18.87 (4.4) 
Bulimia nervosa 5,898 (0.2) 129 (<0.1) 5,769 (0.4) 21.80 (4.7) 21.66 (3.9) 
Autoimmune diseases 
Any autoimmune disease 111,401 (4.4) 48,796 (3.7) 62,605 (5.1) 14.67 (8.2) 15.76 (8.1) 
Celiac disease 19,730 (0.8) 7,274 (0.6) 12,456 (1.0) 10.31 (6.9) 11.83 (7.5) 
Crohn’s disease 8,786 (0.3) 4,377 (0.3) 4,409 (0.4) 18.60 (6.4) 19.68 (6.3) 
Ulcerative colitis 10,809 (0.4) 5,752 (0.4) 5,057 (0.4) 19.81 (6.3) 20.32 (6.4) 
Psoriasis 18,782 (0.7) 8,787 (0.7) 9,995 (0.8) 19.14 (7.4) 18.82 (7.0) 
Arthritis 6,288 (0.2) 1,869 (0.1) 4,419 (0.4) 13.97 (8.4) 16.38 (8.2) 
Lupus  1,107 (<0.1) 186 (<0.1) 921 (<0.1) 17.94 (7.4) 20.63 (6.2) 
Type 1 diabetes 19,237 (0.8) 10,608 (0.8) 8,629 (0.7) 13.93 (6.7) 13.19 (6.5) 
aEating disorder groups are not mutually exclusive. “Other eating disorder” includes bulimia nervosa and eating 
disorder not otherwise specified. “Any eating disorder” includes anorexia nervosa, bulimia nervosa, and eating 
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disorder not otherwise specified. Bulimia nervosa statistics are based on diagnoses made since 1997. Incidence 
cases regardless of prior diagnoses were assigned to each eating disorder group: individuals were assigned to 




Figure 1a. Hazard by age for each autoimmune disease for men (left) and women (right) 
 
 
AN =anorexia nervosa, BN = bulimia nervosa, OED = other eating disorder 















Figure 2a-d. Hazard Ratios (HR) in men 2a-b and women 2c-d. Figures 2a and 2c depict 
HR for those who develop an eating disorder after autoimmune disease diagnosis. Figures 2b 
and 2d depict HR for those who develop an autoimmune disease after eating disorder 
diagnosis. AN =anorexia nervosa, AED = any eating disorder, OED = other eating disorder, 





1. Table S1. Table of references of previous association of autoimmune diseases and eating disorders 
2. Table S2. Autoimmune disease diagnostic codes for Swedish ICD-Revisions 8 and 9 and for ICD-10. 
3. Table S3a. Hazard ratios evaluating subsequent risk of eating disorders in men with autoimmune diseases. 
4. Table S3b. Hazard ratios evaluating subsequent risk of eating disorders in women with autoimmune diseases. 
5. Table S4a. Hazard ratios evaluating subsequent risk of autoimmune diseases in men with eating disorders. 
6. Table S4b. Hazard ratios evaluating subsequent risk of autoimmune diseases in women with eating disorders. 





















Table S1. Previous association of autoimmune diseases and eating disorders. 
Autoimmune 
diseases 
Description Anorexia nervosa Other eating disorders 
Celiac disease Gluten intolerance with mucosa 
destruction in the small intestine 
(Kaur, Shimoni, & Wallach, 2017; 
Lebwohl, Ludvigsson, & Green, 
2015) 
Statistical association 
Register-based nationwide study (Mårild et 
al., 2017) 
Retrospective patient cohort (Wotton, James, 
& Goldacre, 2016) 
Cross-sectional study (Karwautz et al., 2008) 
Retrospective study (Nacinovich et al., 2017) 
Case reports (Leffler, Dennis, Edwards 
George, & Kelly, 2007; Ricca et al., 2000; 
Yucel, Ozbey, Demir, Polat, & Yager, 2006) 
Statistical association 
Register-based nationwide study 
(Butwicka et al., 2017) 
Retrospective patient cohort (Wotton 
et al., 2016) 
Cross-sectional study (Karwautz et 
al., 2008) 
Case reports (Jost et al., 2005; Leffler 





No statistical association 
Retrospective patient cohort (Raevuori et al., 
2014) 
No statistical association 
Retrospective patient cohort 
(Raevuori et al., 2014) 
Cross-sectional survey (Babio et al., 
2018) 
Crohn’s disease Chronic inflammatory bowel disease 
(Torres, Mehandru, Colombel, & 
Peyrin-Biroulet, 2017) 
Statistical association 
Retrospective patient cohort (Raevuori et al., 
2014; Wotton et al., 2016) 
Case reports (Baylé & Bouvard, 2003; 
Mallett & Murch, 1990; Solmi, Santonastaso, 
Caccaro, & Favaro, 2013) 
Statistical association 
Retrospective patient cohort 
(Raevuori et al., 2014) 






No statistical association No statistical association 
Retrospective patient cohort (Wotton 
et al., 2016) 
Ulcerative colitis Chronic inflammatory bowel disease 
(Ananthakrishnan, 2015) 
Statistical association 











No statistical association 
Retrospective patient cohort (Raevuori et al., 
2014) 
No statistical association 
Retrospective patient cohort 
(Raevuori et al., 2014; Wotton et al., 
2016) 
 
Arthritis Inflammatory disease mainly 
affecting the joints (Angelotti et al., 
2017) 
Statistical association 
Retrospective patient cohort (Wotton et al., 
2016) 
Cross-sectional study (Ghadirian, 
Engelsmann, Leichner, & Marshall, 1993) 
Case report (Dalbeth & Callan, 2002) 
Statistical association 
Retrospective patient cohort (Wotton 
et al., 2016) 






No statistical association 
Retrospective patient cohort (Raevuori et al., 
2014) 
No statistical association 
Retrospective patient cohort 
(Raevuori et al., 2014) 
 
 
Psoriasis Autoimmune disease with thick, dry, 
red skin lesions accompanied by pain 
and itching (Greb et al., 2016) 
Statistical association 
Retrospective patient cohort (Wotton et al., 
2016) 
Statistical association 
Retrospective patient cohort (Wotton 
et al., 2016) 
Cross-sectional study (Altunay et al., 





No statistical association 
Retrospective patient cohort (Raevuori et al., 
2014) 
No statistical association 
Retrospective patient cohort (Kimball 
et al., 2012; Raevuori et al., 2014) 
Patient cohort (Kimball et al., 2012) 
 
Lupus  Systemic autoimmune disease which 
affects several organs, such as 
kidneys and skin, can be 
Statistical association 
Case reports (Bambery, Malhotra, Kaur, 
Chadda, & Deodhar, 1987; Sloan, Gallagher, 
Statistical association 
accompanied by diseases-specific 
facial erythema and sometimes show 
psychiatric symptoms (Moulton et 
al., 2017) 
& Walsh, 1998; Toulany, Katzman, 





No statistical association 
Retrospective patient cohort (Raevuori et al., 
2014; Wotton et al., 2016) 
No statistical association 
Retrospective patient cohort 
(Raevuori et al., 2014; Wotton et al., 
2016) 
Type 1 diabetes Autoimmune disorder affecting the 
Langerhans’ islets of the pancreas 
leading to subsequent diabetes 
mellitus (Katsarou et al., 2017) 
Statistical association 
Retrospective patient cohort (Raevuori et al., 
2014; Scheuing et al., 2014; Takii et al., 
2011; Wotton et al., 2016) 
Survival analysis (Nielsen, Emborg, & 
Mølbak, 2002) 
Case report (Brown & Mehler, 2014; Espes, 
Engström, Reinius, & Carlsson, 2013; 
Franzese et al., 2002) 
Statistical association 
Retrospective patient cohort 
(Raevuori et al., 2014; Scheuing et al., 
2014; Takii et al., 2011; Wotton et al., 
2016) 
Meta-analysis (Mannucci et al., 2005) 
Case report (Feiereis, 1988; Moosavi, 





No statistical association 
Meta-analysis (Mannucci et al., 2005) 
Cohort study (Engström et al., 1999) 
No statistical association 
Cohort study (Engström et al., 1999) 
The paper by Zerwas et al. investigated a variety of autoimmune diseases but combined them together in two broad categories of autoimmune and 
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Table S2. Autoimmune disease diagnostic codes for Swedish ICD Revisions 8 and 9 and for ICD-10. 
 
 ICD-8 ICD-9 ICD-10 
Autoimmune hepatitis 571.99 571E  K730 K731 K732 
 K738 K739 
Autoimmune thyroiditis 245.00 245.01 245.02 245.03 245.04 
245.09 
245C E063 
Autoimmune encephalitis   323W  G048 
Guillain-Barre syndrome 354.01 357A G610 
Multiple sclerosis 340.99 340  G35 
Sjögren’s syndrome 734.90 710C M350 
Thyrotoxicosis  
(Grave’s disease) 
242.00 242.09 242.10 242.20 242A 242B 242C 242D 242E 242W 
242X 
E05 E050 E0509 E051 E052 E053 
E054 E055 E058 E059 
Type 1 diabetes  250.00 250.01 250.02 250.03 250.04 
250.05 250.06 250.07 250.08 250.09 
250 250A 250AA 250AB 250AK 
250B 250BB 250C 250D 250E 250F 
250G 250G9 250H 250X 250XB 
E10  
Crohn’s disease  
(regional enteritis) 
563.00  555 555A 555B 555C 555X K500 K501 K508 K509 
Autoimmune hepatitis, chronic 
active hepatitis 
571.90 571.98 571.99 571E K732 
 
  ICD-8 ICD-9 ICD-10 
Ulcerative colitis 563.10 556  K51 K510 K512 K513 K518 K519 
Primary biliary cirrhosis  571G K743 
Celiac disease 269.00 579A K900 
Ankylosing spondylitis 712.40 720A 720B 720C 720W 720X M45 M081 
Dermatopolymyositis 716.00 716.10 710D 710E  M330 M331 M332  
M339 
Myositis  717.98 728W 729B  M60 M601 M608 M609 
Dermatitis herpetiformis 693.99 694A 694C  L122 L130 
Arthritis (Still’s, juvenile, systematic 
juvenile, idiopathic, seropositive 
rheumatoid arthritis, other 
rheumatoid arthritis) 
712.00 712.10 712.20 712.38 712.39 
712.50 714.93 
714A 714B 714C 714D 
714W 714X 
M058 M059 M080 M060 M061 
M062 M063 M064 M068 M069 
M080 M123 
Lupus (systemic lupus 
erythematosus, discoid lupus 
erythematosus) 
734.10 695.40 710A 695E M321 M328 M329 L930 
Mixed connective tissue disease 734.91 279N M350 M351 M352 M353 M355 
M356 M357  M358 M359 
Myasthenia gravis 733.00 358A G700 
Primary adrenocortical insufficiency 
(other adrenal gland) 
255.10 255E  E271 
 ICD-8 ICD-9 ICD-10 
Pemphigus 694.00 694.01 694.03 694.04 694.09 694E  L100 L101 L102 L103 
 L104 L108 L109 
Pemphigoid 694.02 694F L120 L121 L122 L123 L128 L129 
Polyarteritis nodosa (microscopic 
polyangiitis) 
446.00   446A M300 
Churg-Strauss syndrome 
(Eosinophilic granulomatosis with 
polyangiitis) 
446.10 446.98 446E 446F 446H M301 
Granulomatosis with polyangiitis 
(Wegener’s granulomatosis) 
446.20 446.30 446.38 446.40  446 446A  446E 446F 446G 446H 
725  
M311 M313 M314  
M315 M316 M317  
Psoriasis (vulgaris, psoriatic arthritis, 
generalized familial pustular 
psoriasis) 
 696.00 696.10 696.19 696.98  694F 696A 696B  L400 L401 L402 L403 L404 L405 
L408 L409  
Sarcoidosis 135.97 135.99 135 D860 D861 D862 D863  
D868 D869 




390.97 390.99 391.97 391.99 390 I010 I012 I018 I019 
 ICD-8 ICD-9 ICD-10 
Glomerulonephritis 580.99 581.99 582.00 583.99 581 581A 581B 581C 581D 581W 
581X 582 582A 582B 582C 582E 
582W 582X 583 583A 583B 583C 
583E 583G 583H 583W 583X 
N00 N01 N03 N05 
Kawasaki disease  446B  M303 
Raynaud’s syndrome 443.00 443A I730 
Interstitial cystitis 595.04 595B  N301 
Schnitzler syndrome (Muckle-Wells 
syndrome) 







Table S3a. Results, hazard ratios (HR) and 95% confidence intervals (CI) from Cox proportional hazard 
regression models evaluating subsequent risk of eating disorders in men with autoimmune diseases. All 
models are adjusted for calendar-time, age, and socioeconomic status. False Discovery Rate corrected p-
values (Q) and p-values (P) presented. Due to missing values for some of the second diagnoses the 












AN 48,409 44 (0.1) 1.71 1.16, 2.51 0.12 0.007 
OED 48,409 83 (0.2) 1.82 1.40, 2.37 <0.001 <0.001 
AED 48,409 108 (0.2) 1.78 1.40, 2.26 <0.001 <0.001 
BN 48,409 10 (<0.1) 1.56 0.63, 3.82 >.99 0.34 
Celiac disease 
AN 7,247 7 (0.1) 1.58 0.65, 3.81 >.99 0.31 
OED 7,247 15 (0.2) 1.62 0.87, 3.01 >.99 0.13 
AED 7,247 21 (0.3) 1.82 1.07, 3.08 0.40 0.03 
BN 7,247 <4 -- -- -- -- 
Crohn's 
disease 
AN 4,338 5 (0.1) 1.85 0.46, 7.41 >.99 0.39 
OED 4,338 5 (0.1) 1.68 0.63, 4.49 >.99 0.30 
AED 4,338 9 (0.2) 1.75 0.73, 4.20 >.99 0.21 
BN 4,338 <4 -- -- -- -- 
Ulcerative 
colitis 
AN 5,671 <4 -- -- -- -- 
OED 5,671 5 (0.1) 1.42 0.53, 3.80 >.99 0.48 
AED 5,671 6 (0.1) 1.49 0.62, 3.60 >.99 0.37 
BN 5,671 <4 -- -- -- -- 
Arthritis 
AN 1,859 <4 -- -- -- -- 
OED 1,859 7 (0.4) 4.57a 2.05, 10.19a 0.009 a <0.001 a 
AED 1,859 7 (0.4) 3.67a 1.65, 8.18a 0.05 a 0.001 a 
BN 1,859 <4 -- -- -- -- 
Lupus  
AN 186 <4 -- -- -- -- 
OED 186 <4 -- -- -- -- 
AED 186 <4 -- -- -- -- 
BN 186 <4 -- -- -- -- 
Psoriasis 
AN 8,676 <4 -- -- -- -- 
OED 8,676 9 (0.1) 1.41 0.63, 3.14 >.99 0.40 
AED 8,676 10 (0.1) 1.37 0.65, 2.89 >.99 0.40 
BN 8,676 <4 -- -- -- -- 
Type 1 
diabetes 
AN 10,544 8 (0.1) 1.50 0.67, 3.34 >.99 0.33 
OED 10,544 22 (0.2) 2.12 1.31, 3.42 0.05 0.002 
AED 10,544 26 (0.3) 1.91 1.22, 3.01 0.11 0.005 
BN 10,544 <4 -- -- -- -- 
AN = anorexia nervosa; OED = other eating disorder; AED = any eating disorder; BN = bulimia nervosa - 
diagnosed since 1997; Dx = diagnosis.  
n = number of individuals; % = percent 
a = The assumption of proportional hazards ratios was violated 










Table S3b. Results, hazard ratios (HR) and 95% confidence intervals (CI), from Cox proportional hazard 
regression models evaluating subsequent risk of eating disorders in females with autoimmune diseases. 
All models are adjusted for calendar-time, age, and socioeconomic status. False Discovery Rate corrected 
p-values (Q) and p-values (P) presented. Due to missing values for some of the second diagnoses the 







Second Dx  




AN 61,953 947 (1.5) 1.59 1.45, 1.73 <0.001 <0.001 
OED 61,947 1,712 (2.8) 1.71 1.61, 1.81 <0.001 <0.001 
AED 61,947 2,100 (3.4) 1.62 1.53, 1.72 <0.001 <0.001 
BN 61,950 500 (0.8) 1.57 1.40, 1.76 <0.001 <0.001 
Celiac 
disease 
AN 12,382 188 (1.5) 1.50 1.32, 1.71 <0.001 <0.001 
OED 12,379 300 (2.4) 1.47 1.26, 1.71 <0.001 <0.001 
AED 12,379 375 (3.0) 1.45 1.28, 1.63 <0.001 <0.001 
BN 12,381 72 (0.6) 1.34 1.03, 1.74 0.15 0.03 
Crohn's 
disease 
AN 4,337 77 (1.8) 1.89 1.35, 2.63 0.002 <0.001 
OED 4,337 134 (3.1) 1.63 1.27, 2.08 0.001 <0.001 
AED 4,337 164 (3.8) 1.61 1.28, 2.02 <0.001 <0.001 
BN 4,337 26 (0.6) 0.75 0.42, 1.36 >.99 0.35 
Ulcerative 
colitis 
AN 4,979 67 (1.4) 1.38 0.96, 1.99 0.46 0.08 
OED 4,979 129 (2.6) 1.52 1.20, 1.92 0.004 <0.001 
AED 4,979 162 (3.3) 1.49 1.19, 1.86 0.004 <0.001 
BN 4,979 41 (0.8) 1.18 0.76, 1.83 >.99 0.46 
Arthritis 
AN 4,374 56 (1.3) 1.27 0.89, 1.82 >.99 0.19 
OED 4,374 94 (2.2) 1.11 0.85, 1.46 >.99 0.45 
AED 4,374 116 (2.7) 1.11 0.87, 1.43 >.99 0.40 
BN 4,374 27 (0.6) 0.82 0.47, 1.45 >.99 0.50 
Lupus  
AN 921 13 (1.4) 2.39a 1.24, 4.60a 0.06 a 0.009a 
OED 921 28 (3.0) 1.83 1.10, 3.03 0.12 0.02 
AED 921 32 (3.5) 1.81 1.12, 2.91 0.09 0.02 
BN 921 7 (0.8) 0.64 0.16, 2.55 >.99 0.52 
Psoriasis 
AN 9,860 107 (1.1) 1.08 0.81, 1.44 >.99 0.59 
OED 9,859 237 (2.4) 1.33 1.11, 1.59 0.02 0.002 
AED 9,859 278 (2.8) 1.27 1.07, 1.50 0.05 0.007 
BN 9,860 74 (0.8) 1.22 0.88, 1.69 >.99 0.24 
Type 1 
diabetes 
AN 8,568 125 (1.5) 1.71 1.41, 2.08 <0.001 <0.001 
OED 8,566 316 (3.7) 2.53 2.25, 2.85 <0.001 <0.001 
AED 8,566 346 (4.0) 2.19 1.96, 2.46 <0.001 <0.001 
BN 8,566 120 (1.4) 3.22 2.65, 3.91 <0.001 <0.001 
AN = anorexia nervosa; OED = other eating disorder; AED = any eating disorder; BN = bulimia nervosa - 
diagnosed since 1997; Dx = diagnosis.  











Table S4a.  Results, hazard ratios (HR) and 95% confidence intervals (CI), from Cox proportional hazard 
regression models evaluating subsequent risk of autoimmune diseases in men with eating disorders. All 
models are adjusted for calendar-time, age, and socioeconomic status. False Discovery Rate corrected p-
values (Q) and p-values (P) presented. Due to missing values for some of the second diagnoses the 







Second Dx  
n (%) 




696 41 (5.9) 1.40 0.81, 2.42 >.99 0.22 
Celiac disease 699 6 (0.9) 2.31 0.58, 9.25 >.99 0.24 
Crohn’s disease 700 5 (0.7) 0.75 0.11, 5.36 >.99 0.78 
Ulcerative colitis 699 <4 -- -- -- -- 
Arthritis 699 <4 -- -- -- -- 
Lupus 700 <4 -- -- -- -- 
Psoriasis 700 <4 -- -- -- -- 




1,308 73 (5.6) 1.42 0.91, 2.20 >.99 0.12 
Celiac disease 1,317 13 (1.0) 3.79a 1.58, 9.12a 0.12a 0.003a 
Crohn’s disease 1,319 5 (0.4) 0.50 0.07, 3.54 >.99 0.49 
Ulcerative colitis 1,318 5 (0.4) 0.37 0.05, 2.64 >.99 0.32 
Arthritis 1,317 5 (0.4) -- -- -- -- 
Lupus 1,319 <4 -- -- -- -- 
Psoriasis 1,317 7 (0.5) 0.79 0.26, 2.46 >.99 0.69 




1,677 96 (5.7) 1.45 1.01, 2.09 >.99 0.05 
Celiac disease 1,687 18 (1.1) 3.75a 1.79, 7.88a 0.06a <0.00
1a 
Crohn’s disease 1,690 9 (0.5) 0.70 0.18, 2.82 >.99 0.62 
Ulcerative colitis 1,689 6 (0.4) 0.26 0.04, 1.84 >.99 0.18 
Arthritis 1,688 5 (0.3) -- -- -- -- 
Lupus 1,690 <4 -- -- -- -- 
Psoriasis 1,688 8 (0.5) 0.57 0.18, 1.76 >.99 0.33 




124 10 (8.1) 4.32a 1.80, 10.39a 0.07 0.001a 
Celiac disease 124 <4 -- -- -- -- 
Crohn’s disease 124 <4 -- -- -- -- 
Ulcerative colitis 124 <4 -- -- -- -- 
Arthritis 124 <4 -- -- -- -- 
Lupus 124 <5 -- -- -- -- 
Psoriasis 124 <4 -- -- -- -- 
Type 1 diabetes 124 <4 -- -- -- -- 
AN = anorexia nervosa; OED = other eating disorder; AED = any eating disorder; BN = bulimia nervosa - 
diagnosed since 1997; Dx = diagnosis.  
n = number of individuals; % = percent 
a = The assumption of proportion hazards ratios was violated 
-- = Not applicable
Table S4b.  Results, hazard ratios (HR) and 95% confidence intervals (CI), from Cox proportional hazard 
regression models evaluating subsequent risk of autoimmune diseases in women with eating disorders. 
All models are adjusted for calendar-time, age, and socioeconomic status. False Discovery Rate corrected 
p-values (Q) and p-values (P) presented. Due to missing values for some of the second diagnoses the 








n (%)   




11,287 863 (7.7) 1.42 1.27, 1.58 <0.001 <0.001 
Celiac disease 11,343 159 (1.4) 1.83 1.40, 2.39 <0.001 <0.001 
Crohn’s disease 11,370 75 (0.7) 1.40 1.01, 1.94 0.38 0.05 
Ulcerative colitis 11,370 65 (0.6) 1.11 0.79, 1.55 >.99 0.56 
Arthritis 11,366 50 (0.4) 1.32 0.88, 1.97 >.99 0.18 
Lupus 11,372 13 (0.1) 0.69 0.26, 1.85 >.99 0.46 
Psoriasis 11,369 104 (0.9) 1.02 0.82, 1.40 >.99 0.61 




19,069 1,565 (8.2) 1.58 1.45, 1.73 <0.001 <0.001 
Celiac disease 19,178 258 (1.4) 1.69 1.32, 2.17 <0.001 <0.001 
Crohn’s disease 19,215 129 (0.7) 1.72 1.33, 2.22 <0.001 <0.001 
Ulcerative colitis 19,216 126 (0.7) 1.26 0.96, 1.65 0.63 0.09 
Arthritis 19,213 87 (0.5) 1.63 0.94, 2.82 0.16 0.01 
Lupus 19,220 28 (0.2) 1.39 0.62, 3.11 0.62 0.08 
Psoriasis 19,212 231 (1.2) 1.38 1.13, 1.68 0.02 0.002 




24,196 1,915 (7.9) 1.53 1.42, 1.65 <0.001 <0.001 
Celiac disease 24,327 316 (1.3) 1.72 1.40, 2.10 <0.001 <0.001 
Crohn’s disease 24,381 159 (0.7) 1.63 1.31, 2.03 <0.001 <0.001 
Ulcerative colitis 24,382 159 (0.7) 1.28 1.02, 1.61 0.27 0.03 
Arthritis 24,376 106 (0.4) 1.37 1.04, 1.82 0.27 0.03 
Lupus 24,386 32 (0.1) 1.33 0.80, 2.23 >.99 0.27 
Psoriasis 24,377 271 (1.1) 1.25 1.04, 1.49 0.16 0.02 






5,583 474 (8.5) 1.48 1.25, 1.75 <0.001 <0.001 
Celiac disease 5,602 64 (1.1) 1.25 0.71, 2.20 >.99 0.45 
Crohn’s disease 5,610 26 (0.5) 1.32 0.78, 2.23 >.99 0.30 
Ulcerative colitis 5,610 41 (0.7) 1.42 0.91, 2.24 0.76 0.13 
Arthritis 5,610 27 (0.5) 1.66 0.96, 2.87 0.54 0.07 
Lupus 5,610 7 (0.1) 2.01 0.83, 4.84 0.76 0.12 
Psoriasis 5,609 73 (1.3) 1.37 0.95, 1.97 0.63 0.09 
Type 1 diabetes 5,599 109 (0.2) 1.22 0.61, 2.45 >.99 0.57 
AN = anorexia nervosa; OED = other eating disorder; AED = any eating disorder; BN = bulimia nervosa - 
diagnosed since 1997; Dx = diagnosis.  








Table S5.  Temporal proximity between first and second diagnosis. Results, hazard ratios (HR) and 95% 
confidence intervals (CI), from Cox proportional hazard regression models evaluating subsequent risk of 





N Years Between 














≤1 1,384 587 (42.4) 2.05 1.63, 2.58 <0.001 <0.001 
1-4 2,904 134 (4.6) 1.49 1.26, 1.77 <0.001 <0.001 




≤1 973 123 (12.6) 3.17 1.99, 5.03 <0.001 <0.001 
1-4 2,945 23 (0.8) 1.84 1.22, 2.78 0.007 0.003 






≤1 2,924 1,148 (39.3) 2.16 1.77, 2.50 <0.001 <0.001 
1-4 6,058 220 (3.6) 1.47 1.28, 1.69 <0.001 <0.001 




≤1 2,109 216 (10.2) 2.65 1.76, 4.00 <0.001 <0.001 
1-4 6,222 28 (0.5) 1.55 1.06, 2.26 0.04 0.02 




≤1 1,987 82 (4.1) 2.88 1.81, 4.57 <0.001 <0.001 
1-4 6,304 24 (0.4) 1.41 0.93, 2.14 0.13 0.11 
>4 10,924 23 (0.2) 1.54 1.00, 2.37 0.08 0.05 
Psoriasis  
  
≤1 2,039 142 (7.0) 1.48 0.94, 2.32 0.12 0.09 
1-4 6,275 45 (0.7) 1.32 0.97, 1.80 0.10 0.08 






≤1 3,385 1,344 (39.7) 2.14 1.84, 2.50 <0.001 <0.001 
1-4 6,934 284 (4.1) 1.48 1.31, 1.67 <0.001 <0.001 




≤1 2,424 254 (10.5) 2.89 2.05, 4.07 <0.001 <0.001 
1-4 7,079 39 (0.6) 1.58 1.15, 2.18 0.009 0.005 




≤1 2,288 95 (4.2) 3.02 2.00, 4.55 <0.001 <0.001 
1-4 7,163 29 (0.4) 1.34 0.92, 1.96 0.14 0.13 






≤1 738 341 (46.2) 1.44 0.98, 2.12 0.09 0.06 
1-4 1,687 62 (3.7) 1.25 0.95, 1.64 0.13 0.11 
>4 3,158 71 (2.3) 1.79 1.39, 2.31 <0.001 <0.001 
AN = anorexia nervosa, OED = other eating disorder, AED = any eating disorder, BN = bulimia nervosa - diagnosed 
since 1997; Dx = diagnosis, n = number of individuals,  % = percent. All estimates are adjusted for calendar-time, 
age, and socioeconomic status. False Discovery Rate corrected p-values (Q) and p-values (P) presented. Temporal 
proximity results only for estimates that survived FDR correction in Table 2a-b and Table 3a-c. 
